SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following FDA approval for its oral Wegovy pill, a significant development in the weight-loss drug market. The community is actively discussing the convenience of a pill over injections and its potential to capture substantial market share, intensifying competition with Eli Lilly. Many are debating whether this breakthrough will lead to sustained gains and a re-evaluation of the company's valuation.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending due to a massive parabolic surge following its recent NYSE listing, fueling intense community discussion and FOMO around its low-float status and the broader bullish sentiment in the space sector. While many speculate about continued exponential gains, others are cautioning about the company's early-stage operations, negative earnings, and the potential for a sharp correction.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares are trending as gold prices surge to new record highs, driven by escalating geopolitical tensions and widespread expectations for future interest rate cuts. The community is engaged in a lively debate, with many viewing this as the onset of a generational super cycle, while others caution about a potential bubble and significant corrections. A key talking point revolves around gold's strong performance compared to other asset classes, particularly Bitcoin.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent drill results indicating significant high-grade silver in its Vortex system, fueling strong community discussion about its long-term potential. Amid a favorable environment for precious metals, the stock is drawing fervent bullish sentiment, notably from those tracking substantial institutional investments, though some express skepticism regarding its operational readiness and short-term volatility.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is actively trending following its announcement of a new joint development agreement with an unnamed top-10 global automaker, marking the completion of a key commercial milestone. The community is split between bullish investors anticipating breakthroughs in solid-state battery commercialization and a NASDAQ listing, and skeptical traders expressing frustration over unnamed partners and perceived market manipulation. This ongoing debate highlights the company's critical transition from R&D to industrialization within the EV battery sector.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending following the recent Anthony Joshua victory over Jake Paul, an outcome that reportedly saved the sportsbook from nearly $100 million in potential payouts. Concurrently, the launch of its new DraftKings Predictions platform is a major talking point, with the community assessing its potential to expand market reach into new states and compete against other prediction market operators. This strategic move, alongside favorable NFL outcomes boosting Q4 performance, positions DraftKings amid an evolving regulatory landscape and intense competition.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending intensely as the community reacts to Novo Nordisk's recent oral GLP-1 FDA approval, largely perceiving it as a significant de-risking event for the broader oral weight-loss market. Investors are actively comparing VKTX's VK2735 oral and injectable programs against new data from rivals like Eli Lilly, highlighting its potential for best-in-class efficacy with a more favorable tolerability profile amidst discussions of competitor side effects. This dynamic, coupled with anticipation around VKTX's oral VK2735 FDA meeting and the upcoming J.P. Morgan conference, is fueling widespread speculation about major partnerships or an acquisition.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to promising interim Phase 1 data for its obesity drug, WVE-007, which uniquely demonstrates fat loss while preserving muscle mass and fewer gastrointestinal side effects compared to current GLP-1 therapies. This has ignited strong community speculation about its potential as a disruptive "game changer" and an attractive acquisition target for major pharmaceutical companies. However, discussions also reflect caution surrounding the early-stage nature of the data and the impact of recent capital raises and insider trading activity.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a top trending stock as its oral GLP-1, orforglipron, demonstrated successful weight loss maintenance, and its triple-G drug, retatrutide, posted strong Phase 3 efficacy, though community discussion around the latter notes its side effect profile. The market is keenly watching LLY's competitive positioning, especially as it navigates a burgeoning oral GLP-1 space, intensified price reductions for Zepbound, and ongoing debates about its lofty valuation.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as its merger target, Infleqtion, garners significant attention for new strategic partnerships, including with Safran for GPS-independent timing solutions and collaboration with Oak Ridge National Labs on quantum-HPC integration with NVIDIA. The community is actively discussing Infleqtion's validated quantum sensing technology, robust government contracts, and perceived undervaluation compared to peers. Many anticipate a re-rating and increased institutional interest once the merger closes and the ticker changes to INFQ, positioning it as a key player in critical "Sovereign Tech."

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assenagon Asset Management S.A. Purchases 739,982 Shares of Alphatec Holdings, Inc. $ATEC

Assenagon Asset Management S.A. lifted its position in Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 7,083.2% in the third quarter, according to the company in its most recent 13F filing...

Alphatec (NASDAQ:ATEC) COO Scott Lish Sells 19,900 Shares

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) COO Scott Lish sold 19,900 shares of the firm's stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an...

Scott Lish Sells 19,900 Shares of Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) COO Scott Lish sold 19,900 shares of the company's stock in a transaction on Tuesday, December 16th. The shares were sold at an average price...

Alphatec (NASDAQ:ATEC) Director Sells $4,915,000.00 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) Director David Pelizzon sold 250,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at...

Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Rating of "Moderate Buy" from Analysts

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven ratings firms that are presently covering the company, Marketbeat reports. One...

Alphatec (NASDAQ:ATEC) EVP David Sponsel Sells 21,106 Shares

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) EVP David Sponsel sold 21,106 shares of the company's stock in a transaction on Wednesday, December 10th. The stock was sold at an average...

Alphatec (NASDAQ:ATEC) Director Sells $636,000.00 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) Director David Demski sold 30,000 shares of Alphatec stock in a transaction on Thursday, December 11th. The shares were sold at an average...

Alphatec (NASDAQ:ATEC) EVP Sells 32,584 Shares

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) EVP Craig Hunsaker sold 32,584 shares of the company's stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at...

Alphatec (NASDAQ:ATEC) EVP Sells $438,793.74 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) EVP David Sponsel sold 21,106 shares of the firm's stock in a transaction dated Wednesday, December 10th. The stock was sold at an average...

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 75,143 Shares of Alphatec Holdings, Inc. $ATEC

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 38.7% in the 2nd quarter, according to...

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.04	--	--	N/A
Q3 '25	-$0.03	$0.03	195.62%	BEAT
Q2 '25	-$0.04	$0.02	145.16%	BEAT
Q1 '25	-$0.12	-$0.11	8.26%	BEAT
Q4 '24	-$0.05	-$0.03	37.35%	BEAT

ATEC
Alphatec Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ATEC News

ATECAlphatec Holdings Inc